300858.SZ
科拓生物
SZSE · Healthcare · C 制造业 · CN
CNY 14.55
−5.52%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
26.8x
Market Cap
CNY 3.83B
MomentumView details →
1D Return
−5.52%
YTD Return
−11.57%
RSI (14)
51.2
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
26.8x
Market Cap
CNY 3.83B
RSI (14)
51.2
MomentumView details →
1D Return
−5.52%
YTD Return
−11.57%
Similar companies
Latest newsMore news →
Kebot Bio announced that as of August 31, 2026, it had repurchased 4.7876 million shares for approximately 70 million yuan under its ongoing buyback program.1d agoKebotu Bio announced that shareholder Ningbo Shunyi reduced its stake by 0.65% (1.7001 million shares) via centralized bidding, completing its reduction plan, while Ningbo Kehuida did not reduce shares.11d ago